FOXP3 expression in tumor cells and implications for cancer progression

Tiziana Triulzi1, Elda Tagliabue, Andrea Balsari

  • 1Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.

Insights

Forkhead box protein 3 (FOXP3) regulates T cells but is also found in cancer cells. Its role in tumors is debated, with conflicting evidence on whether it suppresses or promotes cancer progression.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • Forkhead box protein 3 (FOXP3) is a transcriptional regulator crucial for regulatory T cell development and function.
  • FOXP3 expression is not limited to immune cells, having been identified in various non-hematopoietic and tumor cells.

Purpose of the Study:

  • To review the diverse roles of FOXP3 in cancer cells.
  • To explore the controversial functions of FOXP3 in tumor progression and metastasis.

Main Methods:

  • Literature review of existing studies on FOXP3 expression in cancer.
  • Analysis of in vitro and human sample data regarding FOXP3's impact on tumor cells.

Main Results:

  • FOXP3 expression in tumor cells has been linked to metastatic spread in human studies.
  • In vitro research suggests FOXP3 may possess tumor-suppressive functions.

Conclusions:

  • The role of FOXP3 in cancer is complex and context-dependent.
  • Further research is needed to elucidate FOXP3's precise function in tumorigenesis and metastasis.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...